First Time Loading...

Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 15.55 USD 5.57% Market Closed
Updated: Apr 29, 2024

Arcus Biosciences Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arcus Biosciences Inc
Cash from Investing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Arcus Biosciences Inc
NYSE:RCUS
Cash from Investing Activities
$194m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Investing Activities
-$2B
CAGR 3-Years
62%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Cash from Investing Activities
-$2.3B
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
-24%
Amgen Inc
NASDAQ:AMGN
Cash from Investing Activities
-$26.2B
CAGR 3-Years
-69%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Investing Activities
-$3.1B
CAGR 3-Years
N/A
CAGR 5-Years
-73%
CAGR 10-Years
-50%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Investing Activities
-$3.2B
CAGR 3-Years
-256%
CAGR 5-Years
-17%
CAGR 10-Years
-25%

See Also

What is Arcus Biosciences Inc's Cash from Investing Activities?
Cash from Investing Activities
194m USD

Based on the financial report for Dec 31, 2023, Arcus Biosciences Inc's Cash from Investing Activities amounts to 194m USD.